We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
DN | Delta 9 Cannabis Inc | 0.025 | 0.005 | 25.00% | 1,087,798 |
FT | Fortune Minerals Limited | 0.075 | 0.015 | 25.00% | 1,439,935 |
PPR | Prairie Provident Resources Inc | 0.06 | 0.01 | 20.00% | 119,793 |
GOOS | Canada Goose Holdings Inc | 18.59 | 3.07 | 19.78% | 897,309 |
IGX | Intelgenx Technologies Corp | 0.24 | 0.035 | 17.07% | 7,000 |
EGLX | Enthusiast Gaming Holdings Inc | 0.16 | 0.02 | 14.29% | 466,908 |
AMC | Arizona Metals Corp | 2.34 | 0.28 | 13.59% | 382,000 |
CFF | Conifex Timber Inc | 0.59 | 0.07 | 13.46% | 500 |
LSPD | Lightspeed Commerce Inc | 19.70 | 2.33 | 13.41% | 1,458,687 |
CDR | Condor Energies Inc | 2.01 | 0.20 | 11.05% | 24,505 |
HWO | High Artic Energy Services Inc | 1.44 | 0.12 | 9.09% | 106,569 |
TORONTO, May 16, 2024 /CNW/ - Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) (the "Company" or "Arizona Metals") is delighted to announce key changes in its leadership team to steer the Company into its next phase of growth. To facilitate the progression of Arizona Metals, Marc Pais (CEO) and Paul Reid (Executive Chair) made the decision to initiate an extensive search process for an experienced mine development leadership team.
Total revenue of $230.2 million grew 25% year-over-year and annual revenue exceeded previously-established outlook Net loss and Adjusted EBITDA1Â improved to ($32.5)Â million and $4.4Â million, respectively GPV as a percentage of GTV was 32% in the quarter, up from 19% in the prior year ARPU2Â of ~$431 grew 29% year-over-year with Net Retention Rate of ~110% Lightspeed reports in US dollars and in accordance with IFRS.
Company continues to advance its corticosteroid production platform and anticipates signing a large strategic partnership in Q2 2024 Signed two new program agreements, and advanced three programs to the next phase of development toward commercialization Willow reiterates its expectations of at least doubling its full year 2024 revenues SUNNYVALE, Calif., May 13, 2024 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ingredients, today released its financial and operating results for the three months ended March 31, 2024, reporting significantly reduced costs and further ...
Completes Major Steps Towards Profitability with Best Revenue and Adjusted EBITDA in Over Three Years TORONTO, May 15, 2024 /CNW/ -Â MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three months ended March 31, 2024.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
LWLG | Lightwave Logic Inc | 170 | |
COOP | Mr Cooper Group Inc | 47 | |
NB | Niocorp Developments Ltd | 24 | |
4 | PLPL | Plandai Biotechnology Inc | 44 |
5 | RNVA | Rennova Health Inc | 72 |
6 | RDGL | Vivos Inc | 33 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 65,772.88 | -487.24 | -0.74% | 1.3T | 6,594,602,790 |
ETH | Ethereum | 2,944.03 | -91.40 | -3.01% | 355.58B | 2,412,975,503 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 366,918,754 |
BNB | Binance Coin | 568.55 | -12.88 | -2.22% | 90.58B | 373,071,786 |
SOL | Solana | 158.48 | 0.100 | 0.06% | 70.73B | 1,670,043,504 |
STETH | stETH | 2,931.40 | -86.84 | -2.88% | 29.01B | 6,819,538 |
USDC | USD Coin | 0.9999 | 0.00 | 0.00% | 28.07B | 1,349,097,094 |
XRP | Ripple | 0.5128 | -0.0065 | -1.25% | 28.04B | 323,215,032 |
TONCOIN | Wrapped TON Coin | 6.56 | -0.46542 | -6.63% | 22.85B | 307,240,600 |
DOGE | Dogecoin | 0.14978 | -0.00564 | -3.63% | 21.56B | 579,576,180 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions